Don't kill the messenger RNA! First mRNA stabilizing substance could open new ways in the development of innovative mRNA therapeutics Date: October 16, 2024 Source: Max Planck Institute of ...

Policy, funding, and public apathy hold back the search for more advanced COVID vaccines — but researchers persist and have ...

The article by Sarfaraz K. Niazi, PhD, argues that the FDA’s classification of future copies of messenger RNA (mRNA) products ...

A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction of disease-causing ...

Researchers unveil the inner mechanisms of the most intricate and complex molecular machine in human biology. Scientists at ...

Cells synthesise messenger RNA (mRNA) using instructions in DNA and then ‘read’ instructions from the mRNA to make functional ...

The Nobel Prize-winning discovery of microRNA has reshaped our understanding of gene regulation. Learn what these tiny ...

Moderna chief executive officer Stéphane Bancel steps down as chief commercial officer, with president Stephen Hoge assuming ...

Moderna (MRNA) shares are getting a boost in Thursday's pre-market trading as the pharmaceutical giant reported an unexpected profit in its third quarter. The company posted $1.86 billion in revenue ...

A recent breakthrough in genetic research has introduced a tool capable of delivering genetic material to developing fetal ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Issuer: CureVac / Key word (s): Conference CureVac to Present at the 12th International mRNA Health Conference 04.11.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this ...